scholarly journals Evidence Supports Early Thrombus Removal in Iliofemoral Venous Thrombosis

2021 ◽  
Vol 61 (2) ◽  
pp. 179-180
Author(s):  
Peter Gloviczki
2015 ◽  
Vol 30 (1_suppl) ◽  
pp. 14-19 ◽  
Author(s):  
RHW Strijkers ◽  
CWKP Arnoldussen ◽  
CHA Wittens

Introduction Acute thrombus removal therapies may reduce post-thrombotic syndrome in certain deep venous thrombosis patients. The LET classification is designed to identify patients at high risk for developing post-thrombotic syndrome in the acute phase using thrombus location and extent. This study evaluates the use of the LET classification to predict post-thrombotic syndrome in a cohort of patients after deep venous thrombosis. Methods A cohort of 660 deep venous thrombosis patients was invited to participate and fill out a questionnaire with Quality of life questionnaires, basic information, a modified self-assessment version of the Villalta scale for post-thrombotic syndrome and potential confounders. Original data on thrombus extension was available, and the LET classes were determined. Obtained information was analysed using ANOVA and in a multiple logistic regression model to correct for confounders. All different LET classes were compared to post-thrombotic syndrome occurrence, post-thrombotic syndrome prediction and disease specific quality of life scores (VEINES-Sym/Qol). Results Three hundred and fifteen patients responded, and in 309 a post-thrombotic syndrome score was distilled. LET I,II,III ( n = 63) had an odds ratio of 3.4(1.2–9.2) for predicting severe post-thrombotic syndrome, and LET II ( n = 17) had an odds ratio of 5.1(1.3–20.8) compared to LET class I ( n = 97). Both the VEINES-Sym and VEINES-Qol score were significantly lower for LET I,II,III compared to LET I, and LET II compared to LET I. Conclusion The LET classification can be used to classify patients according to acute thrombus location and extent. Extensive and centrally located (LET I,II,III) deep venous thrombosis showed the highest probability in developing severe post-thrombotic syndrome and lower disease specific quality of life.


Author(s):  
Zubin Irani ◽  
Sara Zhao

Lower extremity deep venous thrombosis (DVT) may be complicated by pulmonary embolism, post-thrombotic syndrome, and phlegmasia cerulea dolens. Due to these complications, the American Venous Forum now recommends thrombus removal for large or symptomatic thrombus burden. The AngioJet Solent Proxy and Omni thrombectomy sets are indicated for use in iliofemoral and lower extremity veins with a diameter ≥3 mm. The device has quickly become a preferred device among the available mechanical thrombectomy options. The AngioJet system has been demonstrated as both efficacious and safe as a method of thrombectomy in lower extremity DVT. This chapter discusses two techniques to utilize the AngioJet device in iliofemoral DVT.


2018 ◽  
Vol 34 (2) ◽  
pp. 115-127 ◽  
Author(s):  
Mohamed AH Taha ◽  
Andrew Busuttil ◽  
Roshan Bootun ◽  
Alun H Davies

Objectives The aim is to evaluate venous stent patency, the development of post-thrombotic syndrome, recurrence, quality of life and the optimal post-procedural anticoagulation regimen in the treatment of iliofemoral deep venous thrombosis. Method and results EMBASE and Medline databases were interrogated to identify studies in which acute deep venous thrombosis patients were stented. Twenty-seven studies and 542 patients were identified. Primary, assisted primary and secondary patency rates 12 months after stent placement ranged from 74 to 95, 90 to 95 and 84 to 100%, respectively. The observed post-thrombotic syndrome rate was 14.6%. The incidence of stent re-thrombosis was 8%. In 26% of studies, patients received additional antiplatelet therapy. Quality of life questionnaires employed in 11% of studies, demonstrating an improvement in the chronic venous insufficiency questionnaire (22.67 ± 3.01 versus 39.34 ± 6.66). Conclusion Venous stenting appears to be an effective adjunct to early thrombus removal; however, further studies are needed to identify optimal anticoagulant regimen and effect on quality of life.


2017 ◽  
Vol 177 (2) ◽  
pp. 173-184 ◽  
Author(s):  
Ana I. Casanegra ◽  
Robert D. McBane ◽  
Haraldur Bjarnason

2018 ◽  
Vol 7 (3) ◽  
Author(s):  
Mihriban Yalcin ◽  
Eda Godekmerdan Katırcıoglu ◽  
Kamuran Erkoc ◽  
Osman Tiryakioglu

Our aim is to explain follow-up in patients treated with pharmacomechanical thrombectomy (PMT) followed by balloon angioplasty for lower extremity deep venous thrombosis (DVT). A total of 19 patients who underwent PMT for DVT were included in the study. The patients underwent PMT with the Cleaner device after insertion of vena cava filters. The mean age was 45 years (range 20-56). The lesions were on the right side in nine patients and on the left side in 10 patients. Complete thrombus removal was achieved in 14 patients and the remaining five patients underwent balloon angioplasty and stenting to achieve significant patency. In conclusion, our single-center experience with short-term results suggests that PMT with the Cleaner device can be used to successfully manage acute and sub acute DVT.


Sign in / Sign up

Export Citation Format

Share Document